HIV This Week Issue

Welcome to the 71st issue of HIV This Week ! In this issue, we cover male circumcision (does circumcising HIV-infected men reduce transmission to women?; does sex in the wound healing period increase HIV acquisition risk for HIV-negative men?), programme evaluation: equity (Malawi leads the way in equity policy and analysis; how sex and income affect survival and retention in Nyanga’s antiretroviral treatment programme near Cape Town), injecting-drug users (good news on harm reduction in the USA), paediatric outcomes (non-infected kids exposed to antiretroviral drugs in pregnancy do not have intrauterine growth retardation; how many kids starting antiretroviral therapy get immune reconstitution inflammatory syndrome (IRIS)?; avoiding disseminated BCG disease means not vaccinating any infant against TB if they are born to an HIV-positive mother until they are found to be uninfected), health care delivery (Rwanda measures the effects of integrating HIV clinical services into primary health care; what impact do Global Health Initiatives in Zambia have on human resources for antiretroviral treatment roll-out?), people living with HIV (social networks prove a real asset in accessing hard to reach populations in the US), treatment (why you shouldn’t wait to start antiretroviral treatment if you have an opportunistic infection; fugitive data in a trial of therapeutic drug monitoring), reproductive health (jury still out on whether hormonal contraceptives increase HIV disease progression), basic science (how common are long-term nonprogressors and HIV controller patients in France?; elite controllers have it easier with inefficient HIV envelope glycoproteins), resistance (would circulating HIV drug resistance undermine PrEP among young women in Zimbabwe?; WHO’s new surveillance list of drug resistance mutations), sexual behaviour (changes in numbers of sexual partners but discrepancies in HIV prevalence persist between sites in South Africa, Zimbabwe and Uganda), and research financing (high time to make the pie bigger for neglected disease research and development) .